Danaher Corporation $DHR Shares Sold by Greenleaf Trust

Greenleaf Trust cut its stake in shares of Danaher Corporation (NYSE:DHR) by 2.8% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 82,518 shares of the conglomerate’s stock after selling 2,365 shares during the period. Greenleaf Trust’s holdings in Danaher were worth $18,282,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. BlackRock Inc. acquired a new position in shares of Danaher during the second quarter worth $10,492,520,000. Wellington Management Group LLP boosted its stake in Danaher by 10.4% during the second quarter. Wellington Management Group LLP now owns 16,316,834 shares of the conglomerate’s stock worth $3,108,031,000 after acquiring an additional 1,542,310 shares in the last quarter. Jupiter Topco LLC acquired a new stake in Danaher in the second quarter valued at approximately $1,456,317,000. Generation Investment Management LLP bought a new stake in shares of Danaher during the second quarter worth about $1,287,949,000. Finally, Bank of America Corp DE bought a new position in Danaher during the 2nd quarter valued at $993,846,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Performance

DHR stock opened at $232.22 on Monday. The firm has a market cap of $163.37 billion, a price-to-earnings ratio of 38.01, a PEG ratio of 2.92 and a beta of 0.76. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.29 and a current ratio of 1.63. The firm has a 50-day simple moving average of $218.92 and a two-hundred day simple moving average of $201.77. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80.

Danaher (NYSE:DHR) last released its quarterly earnings results on Wednesday, October 21st. The conglomerate reported $2.11 EPS for the quarter, beating the consensus estimate of $1.92 by $0.19. The company had revenue of $6.55 billion for the quarter, compared to analyst estimates of $6.56 billion. Danaher had a net margin of 16.91% and a return on equity of 11.17%. The firm’s revenue was up 8.3% on a year-over-year basis. During the same quarter last year, the business earned $1.89 earnings per share. On average, equities analysts forecast that Danaher Corporation will post 8.59 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th were paid a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.7%. The ex-dividend date was Wednesday, September 30th. Danaher’s dividend payout ratio is currently 26.19%.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the stock. Citigroup lifted their price target on shares of Danaher from $230.00 to $270.00 and gave the stock a “buy” rating in a report on Thursday, October 22nd. The Goldman Sachs Group restated a “buy” rating and set a $275.00 price target on shares of Danaher in a research report on Thursday, October 22nd. DZ Bank cut Danaher from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 27th. Robert W. Baird increased their price objective on Danaher from $246.00 to $254.00 and gave the stock an “outperform” rating in a report on Thursday, October 22nd. Finally, UBS Group restated a “buy” rating and set a $260.00 price objective on shares of Danaher in a research note on Thursday, October 22nd. Eighteen investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, Danaher presently has an average rating of “Moderate Buy” and an average target price of $242.91.

Insider Activity at Danaher

In other Danaher news, CAO Christopher Bouda sold 7,598 shares of Danaher stock in a transaction that occurred on Wednesday, October 28th. The stock was sold at an average price of $234.56, for a total transaction of $1,782,186.88. Following the transaction, the chief accounting officer owned 9,107 shares of the company’s stock, valued at $2,136,137.92. The trade was a 45.48% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Company insiders own 10.80% of the company’s stock.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.